Result
€115,331 ▲ 433%
The result rose in 2025 from €21,646 to €115,331.
FONGHO MEDICAL
Lifetime
19 annual accounts with figures on one time axispeak €211,717 (2025)
€211,717▲ 116%
lowest -€22,166 (2021)
€115,331▲ 433%
peak €258,774 (2020)
€222,780▲ 66.3%
€106,338▼ 65.2%
Board1 name since 2005
1 directorFONGHO Bertrand
Documentsfilings and deeds
31-10-202692 days late
2025micro format
Gross margin from €98,044 to €211,717Result from €21,646 to €115,331Dividend €26,500Equity from €133,950 to €222,780Debts from €305,336 to €106,338Cash from €12,566 to €43,483
Key points
from the 2025 annual accountsChecked score
56
Fair
Financially stronger than 62% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%
A confirmed filing finding caps the score at 59.
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,183 companies (NACE 86, micro).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025
08-2025: 0.5%▲ +0.2 percentage points vs 07-2025
09-2025: 0.5%● unchanged vs 08-2025
10-2025: 0.2%▼ -0.3 percentage points vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.3%▲ +0.1 percentage points vs 06-2026
08-2026: 0.5%▲ +0.2 percentage points vs 07-2026
09-2026: 0.5%● unchanged vs 08-2026
10-2026: 0.8%▲ +0.3 percentage points vs 09-2026highest value
11-2026: 0.2%▼ -0.6 percentage points vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Capped at 59: a confirmed filing finding
Last filed accounts filed 92 days late; 2 of the last 3 accounts late
No registered site in the KBO
lowers risk
Sector: Human health activities (NACE 86)
Founded in 2006
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 55% of them on solvency, 28% on liquidity, 80% on profitability and 84% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 31,368 companies had the same profile as FONGHO MEDICAL has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of FONGHO MEDICAL itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,368 companies, not a prediction for FONGHO MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €12,000 on 30-day terms, only on tighter conditions: the latest accounts were filed more than 90 days after the deadline
Liquidity is ample, with a current ratio of 2.28 (0.87 in 2024), above the usual 1.5. Short-term debt is 30.7% and cash 13.2% of total assets. 32.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 92 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-10-2026, 92 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 10 filingsDeviation from the deadline
2025
92 days late
2024
36 days late
2023
28 days late
2022
31 days late
2021
31 days late
2020
87 days late
2019
54 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 51 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
FB
FONGHO Bertrand
Director, since 01-07-2005
- Bertrand Fonghoannual accounts 2016
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0880293311
Amendment of the articles · Legal-form change · Resignations & appointments
“En assurant la gestion d'un ou plusieurs centres médicaux ou d'un ou de plusieurs cabinets médicaux,en ce…” (deed in French) · Board composition: FONGHO Bertrand (sole director) · General meeting of 29-12-2023 · Gazette deed
Incorporation
published on 06-04-2006 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| FONGHO MEDICAL Mons | €329,119 | €211,717 | 67.7% | - |
| CABINET MEDICAL DES DOCTEURS MEURIS ET JEHIN Jalhay | €373,178 | €217,892 | 55.4% | - |
| Cabinet Médical COUCKE-REY Flémalle | €331,199 | €193,999 | 65.8% | - |
| HUISARTSENPRAKTIJK HYGEIA Hasselt | €328,690 | €230,011 | 5.8% | - |
| DOCTEUR PIERRE LELUBRE Tournai | €240,385 | €223,511 | 71.4% | 0.7 |
| INTHERM-MEDE La Louvière | €348,992 | €267,738 | 60.0% | - |
| DOKTER ALAIN VAN DEN HEUVEL Lier | €294,339 | €208,669 | 13.9% | - |
These companies have the same main activity as FONGHO MEDICAL: general medical practice (NACE 86210). They are comparable in size and age: total assets between €240,000 and €373,000, founded between 2002 and 2008.
Official details
Source: KBO- Status
- Active since 28-03-2006Normal situation
- Activity
- General medical practiceNACE 86210
- Financial year end
- 31 December
- Peppol
- Reachable since 17-03-2026
Insights on FONGHO MEDICAL
FONGHO MEDICAL files the micro format. That format states no turnover. The gross margin rose from €43,582 in 2007 to €211,717 in 2025.
The balance sheet grew most from 2012 to 2013 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FONGHO MEDICAL
- What is the company number of FONGHO MEDICAL?
- The company number of FONGHO MEDICAL is 0880.293.311. The VAT number is the same number with BE in front: BE 0880.293.311.
- Where is FONGHO MEDICAL based?
- The registered office is at Avenue des Sapins (N.) 27, 7020 Mons.Company details
- What does FONGHO MEDICAL do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of FONGHO MEDICAL?
- FONGHO MEDICAL is a private limited company (BV).
- When was FONGHO MEDICAL founded?
- FONGHO MEDICAL was founded on 28-03-2006.
- Is FONGHO MEDICAL still active?
- Yes, FONGHO MEDICAL is an active enterprise in the KBO register.
- What is the turnover of FONGHO MEDICAL?
- The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €211,717 and 65 comparable companies (NACE 862). It probably lies between €320,000 and €530,000. In financial year 2021 turnover was €155,971.Financials
- Is FONGHO MEDICAL profitable?
- In financial year 2025, FONGHO MEDICAL made a profit of €115,331.
- Where can I find the annual accounts of FONGHO MEDICAL?
- FONGHO MEDICAL filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FONGHO MEDICAL due?
- FONGHO MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.